Hospital-onset Clostridium difficile infection rates in persons with cancer or hematopoietic stem cell transplant: a C3IC network report

Infect Control Hosp Epidemiol. 2012 Nov;33(11):1162-5. doi: 10.1086/668023. Epub 2012 Sep 24.

Abstract

A multicenter survey of 11 cancer centers was performed to determine the rate of hospital-onset Clostridium difficile infection (HO-CDI) and surveillance practices. Pooled rates of HO-CDI in patients with cancer were twice the rates reported for all US patients (15.8 vs 7.4 per 10,000 patient-days). Rates were elevated regardless of diagnostic test used.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Cancer Care Facilities
  • Clostridioides difficile / isolation & purification*
  • Clostridium Infections / epidemiology*
  • Cross Infection / epidemiology*
  • Cross Infection / etiology
  • Cross Infection / microbiology
  • Health Care Surveys
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Neoplasms* / drug therapy
  • United States / epidemiology